Artemisinin |
Upregulates the proportion of CD4+ IFN-γ+ T cells and Granzyme B + cytotoxic T lymphocyte while abolishes the immunosuppressive effect of Treg cells and MDSCs |
[96] |
Regulates the expression level of immune mediators by upregulating the T-bet, IFN-γ, TNF-α while downregulating the TGF-b |
Enhances the cytotoxic effect of NK cells and stimulates the granule exocytosis |
[99] |
Modulates their downstream proteins of NK activating receptors including Vav-1 as well as ERK1/2 |
Sensitizes cancer cells to NK cell-induced cytolysis by enhancing conjugation between NK cells and tumor cells |
[100] |
Artesunate |
Enhances the cytotoxicity of γδ T cells via upregulating the expression of granzyme B in γδ T cells |
[97] |
Helps HepG2 cancer cells regain sensitivity to γδ T cells via inhibiting TGF-b secretion |
[101] |
Chloroquine |
CQ-induced autophagy inhibition enhances the immunogenicity of cancer cells, thus enhances DC maturation and T cell response by inducing autophagy inhibition |
[102] |
Promotes cancer cell killer CD8+T cell and downregulates immunosuppressive cells in vivo |
[104] |
Suppresses TGF-b production of the cancer cells in vitro and in vivo |
Downregulates the Immunol response via upregulating the FoxP3 positive Treg cells and reducing the T cytotoxic cells |
[105] |
Hydroxychloroquine |
Sensitizes CML cell to Vγ9Vδ2 T cell-mediated lysis in an autophagy-independent way |
[103] |
Pyrimethamine |
Suppresses Treg cells as well as TH-17 associated immune response, while enhances the cytotoxicity of CD8+ T cells via promoting exocytosis |
[107] |